AMAT vs ISRG: Which Is the Better Buy?

Side-by-side comparison of Applied Materials, Inc. and Intuitive Surgical, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-22.
Applied Materials, Inc. Β· Technology
$394.33
-58.9% upside to fair value
Grade C High Quality
VS
Intuitive Surgical, Inc. Β· Healthcare
$451.29
+130.4% upside to fair value
Grade B High Quality
QuantHub Verdict
ISRG has more upside to fair value (+130.4%). AMAT trades at a lower forward P/E (39.9x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric AMAT ISRG
Current Price $394.33 $451.29
Fair Value Estimate $162.08 $1,039.74
Upside to Fair Value -58.9% +130.4%
Market Cap $312.9B $160.3B
Forward P/E 39.9x 53.8x
EV / EBITDA 31.6x 40.5x
Price / Sales 11.1x 15.2x
Price / FCF 50.5x 64.3x
Revenue Growth YoY -2.1% +23.0%
Gross Margin 48.7% 66.3%
Operating Margin 29.1% 30.5%
Return on Equity 38.9% 17.0%
Dividend Yield 0% 0%
FCF Yield 1.98% 1.55%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
AMAT β€” Applied Materials, Inc.
Applied Materials, Inc. is a leading global provider of semiconductor and display equipment, specializing in materials engineering solutions critical to chip manufacturing. The company benefits from a durable competitive moat supported by its market leadership, innovation engine with over 8,500 patents since 2013, and a strong management team led by CEO Gary E. Dickerson. Despite these strengths,…
ISRG β€” Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading healthcare company specializing in robotic-assisted surgery through its flagship da Vinci system, which has established a durable competitive moat with approximately 10,000 systems installed globally and nearly 17 million procedures performed by the end of 2024. The company benefits from a high-quality business model characterized by 85% recurring revenue, st…
Accumulation Zones
Metric AMAT ISRG
Zone Low $121.56 $779.81
Zone High $137.77 $883.78
In Buy Zone? No Yes
← AMAT Research    ISRG Research β†’    All Research